Churg-Strauss syndrome: Difference between revisions

Line 29: Line 29:


==Management==
==Management==
*Initiation Therapy
===Initiation Therapy===
**Prednisone 0.5-1.5 mg/kg/day
*[[Prednisone]] 0.5-1.5 mg/kg/day
**Cyclophosphamide
*Cyclophosphamide


*Maintenance Therapy
===Maintenance Therapy===
**Azathioprine
*Azathioprine
**Methotrexate
*Methotrexate
**Leflunomide
*Leflunomide
**Inhaled glucocorticoids
*Inhaled glucocorticoids


==Disposition==
==Disposition==

Revision as of 11:19, 7 February 2016

Background

  • Eosinophilic granulomatosis with polyangiitis (EGPA)
  • Chronic sinusitis, asthma, and peripheral eosinophilia
  • Vasculitis of small and medium sized vessels
  • Lung and skin are most commonly involved

Clinical Features

Classically develops in three sequential phases:

  1. Prodrome
    • Atopic diseases, allergic rhinitis, and asthma
  2. Eosinophilic phase
    • Multiorgan involvement, particularly lung and GI tract
    • Caused by eosinophilic infiltration into these organs
  3. Vasculitic phase
    • Life threatening vasculitis associated with vascular and extravascular granulomatosis
    • May present with nonspecific signs such as fever, weight loss, malaise

Differential Diagnosis

  • Aspirin-exacerbated respiratory disease
  • Chronic eosinophilic pneumonia
  • Allergic bronchopulmonary aspergillosis
  • Hypereosinophilic syndrome
  • Other vasculitides

Diagnosis

  • Typically a clinical diagnosis
  • Labs with elevated eosinophils, ESR, CRP, ANCA
  • CXR with transient, patchy opacities

Management

Initiation Therapy

Maintenance Therapy

  • Azathioprine
  • Methotrexate
  • Leflunomide
  • Inhaled glucocorticoids

Disposition

  • Refer to rheumatology

See Also

External Links

References

<UpToDate>